A small clinical trial published last week in the Journal of Psychopharmacology found that therapeutic doses of MDMA, in concert with psychotherapy, reduced the severity of most participants’ PTSD symptoms.
The US Food and Drug Administration has just granted a “Breakthrough Therapy” designation to a treatment that uses psychedelic mushrooms as a therapy for treatment-resistant depression.
Robotics startup LuxAI has created QTrobot, a bot designed to help children with autism learn valuable social skills.
The Empire State’s law, which was reportedly written in 2015, says mental health is “an integral part of our overall health and should be an integral part of health education in New York schools.”
The researchers analyzed the language used by subscribers on the r/depression subreddit, concluding that users’ language improved in nine of 10 categories, suggesting r/depression prompted a “positive emotion change” in users.
The cognitive training, called speed of processing, showed benefits up to 10 years after study participants underwent the mental exercise program, said Frederick W. Unverzagt, PhD, professor of psychiatry at Indiana University School of Medicine.
Billionaire Microsoft co-founder Bill Gates is to invest $50 million in the Dementia Discovery Fund, a venture capital fund that brings together industry and government to seek treatments for the brain-wasting disease.
The U.S. Food and Drug Administration today announced a new comprehensive plan for tobacco and nicotine regulation that will serve as a multi-year roadmap to better protect kids and significantly reduce tobacco-related disease and death.
By 1968, Norwegians had become dissatisfied with the harsh living conditions of the correctional system, and the Norwegian Association for Criminal Reform (KROM) was formed. KROM’s first substantive change to Norwegian penology occurred in 1970, with the abolition of forced labor. In 1975, juvenile delinquency centers were abolished. Reforms in the early 1990s focused on rehabilitation and reducing recidivism.
Throughout the 1950s and 1960s, scientists in several countries conducted extensive research into experimental chemotherapeutic, and psychotherapeutic uses of psychedelic drugs.
